An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...

Health and Human Services Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that ...

The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

The vast majority of positive tests have come from people in Bangor who have either been homeless, injection drug users, or ...

Meghalaya plans to introduce mandatory pre-marital HIV testing following a drastic rise in cases and treatment gaps.